Pyridinone compounds
US7851489B2 · kind B2 · utility
28Cited by
8References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2007 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | Feb 11, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to pyridinone compounds useful for modulating Met kinase, having the following structure:and is further directed to pharmaceutical compositions comprising the compound; and methods for treating proliferative diseases, such as cancer by the administration of this compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.